Psychemedics Research and Development Expenses 2010-2024 | PMD

Psychemedics research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Psychemedics Annual Research and Development Expenses
(Millions of US $)
2023 $1
2022 $1
2021 $1
2020 $1
2019 $2
2018 $2
2017 $1
2016 $1
2015 $2
2014 $1
2013 $1
2012 $1
2011 $1
2010 $0
2009 $0
Psychemedics Quarterly Research and Development Expenses
(Millions of US $)
2024-03-31 $0
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31 $0
2021-12-31 $0
2021-09-30 $0
2021-06-30 $0
2021-03-31 $0
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31 $0
2015-09-30 $0
2015-06-30 $0
2015-03-31 $0
2014-12-31 $0
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.015B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.537B 10.61
Quest Diagnostics (DGX) United States $15.639B 16.16
DaVita (DVA) United States $12.092B 15.02
Encompass Health (EHC) United States $8.769B 22.45
Chemed (CHE) United States $8.598B 26.65
Elanco Animal Health (ELAN) United States $8.421B 21.85
Option Care Health (OPCH) United States $5.225B 19.78
RadNet (RDNT) United States $4.303B 89.60
Amedisys (AMED) United States $3.120B 22.10
LifeStance Health (LFST) United States $2.863B 0.00
Astrana Health (ASTH) United States $2.307B 31.20
Addus HomeCare (ADUS) United States $1.815B 25.97
U.S Physical Therapy (USPH) United States $1.627B 43.54
Pennant (PNTG) United States $0.687B 36.29
Aveanna Healthcare Holdings (AVAH) United States $0.523B 0.00
Atai Life Sciences (ATAI) Germany $0.343B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00